Studies of Dermatologic Diseases Biospecimen Acquisition Protocol

Launched by NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES (NIAMS) · Jun 12, 2015

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the causes of various skin diseases, which can affect people in many ways and sometimes lead to serious health issues. The researchers aim to find better treatments by collecting samples from participants, including blood, stool, and skin samples. Both individuals with skin conditions and healthy volunteers aged 2 and older can take part in this study. Family members of those with skin diseases are also welcomed to join.

If you choose to participate, you will first have a medical history taken and a physical exam, including a detailed skin check. You may be asked to complete a survey about how your skin condition affects your daily life. Participants may need to provide several types of samples and might have up to four skin biopsies within a year, where a small piece of skin is gently removed for testing. This study is currently recruiting participants, and everyone can contribute to important research that could improve skin health for many people.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• * Eligible participants must:
• • Have a dermatologic condition, as determined by the PI or AIs, OR --be at risk for developing a dermatologic condition, as determined by the PI or AIs, OR
• • be a family member of a person with a dermatologic condition OR
• • be a healthy volunteer, as defined as a person with no known significant health problems.
• • Be willing to provide biospecimens for research and clinical studies, and for storage to be used for future research.
• • Subjects of age greater than 0 years old (including only viable neonates) are eligible.
• EXCLUSION CRITERIA:
• • Presence of conditions that, in the judgment of the investigator, may put the subject at undue risk or make them unsuitable for participation in the study.
• • Inability to comply with the requirements of the protocol.